Wave Life Sciences Ltd. (WVE) Positive RestorAATion-2 Clinical Data Update Conference TranscriptSeeking Alpha • 09/03/25
Wave Life Sciences Announces Positive Update from Ongoing RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin DeficiencyGlobeNewsWire • 09/03/25
Wave Life Sciences Reports Second Quarter 2025 Financial Results and Provides Business UpdateGlobeNewsWire • 07/30/25
Wave Life Sciences Second Quarter 2025 Financial Results Scheduled for July 30, 2025GlobeNewsWire • 07/23/25
Wave Life Sciences Announces Oral Presentation of Preclinical Data Supporting WVE-007's Mechanism (INHBE) to Reduce Fat, Preserve Muscle, and Induce Healthy Weight Loss at ADA's Annual Scientific SessionsGlobeNewsWire • 06/20/25
Wave Life Sciences Announces Appointment of Dr. Christopher Wright as Chief Medical OfficerGlobeNewsWire • 05/28/25
Wave Life Sciences Reports First Quarter 2025 Financial Results and Provides Business UpdateGlobeNewsWire • 05/08/25
Analysts Estimate Wave Life Sciences (WVE) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 05/01/25
Wave Life Sciences First Quarter 2025 Financial Results Scheduled for May 8, 2025GlobeNewsWire • 05/01/25
Promising Genomics & Synthetic Biology Stocks to Consider in 2025Zacks Investment Research • 03/28/25
Wave Life Sciences (WVE) Stock Jumps 6.1%: Will It Continue to Soar?Zacks Investment Research • 03/27/25
Wave Life Sciences Stock Jumps On Positive Data From Muscle Disorder Drug, Plans FDA Submission Next YearBenzinga • 03/26/25
Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks of Dosing with WVE-N531GlobeNewsWire • 03/26/25
Wave Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateGlobeNewsWire • 03/04/25
Wave Life Sciences Fourth Quarter and Full Year 2024 Financial Results Scheduled for March 4, 2025GlobeNewsWire • 02/25/25
Wave Life Sciences Announces Initiation of Phase 1 INLIGHT Clinical Trial of WVE-007 in ObesityGlobeNewsWire • 02/06/25